ZBIO logo

ZBIOZenas Biopharma Inc.

$17.76
$0.15
(0.84%)
Today
Closed $17.76
$0.00
(0.00%)
After Hours
Updated: 06:28 PM EDT
Reported EarningsMay 13
Mkt Cap$1.12B
Vol607,218.00
News
all
press releases
Tuesday 5/19 Insider Buying Report: ZBIO, ICFI
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, Zenas Biopharma's Chief Executive Officer, Leon O. Moulder Jr., made a...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Up 7.7% - Still a Buy?
Zenas BioPharma (NASDAQ:ZBIO) Shares Up 7.7% - Should You Buy...
MarketBeat
News Placeholder
Thursday 4/30 Insider Buying Report: ZBIO, PDX
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Zenas Biopharma, a filing with the SEC revealed that on Wednesday, Chief Executi...
Nasdaq News: Markets
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity...
MarketBeat
News Placeholder
Leon Moulder, Jr. Buys 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the company's stock in a transaction that occurred on Tuesday, April 28th. The shares were...
MarketBeat
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) CEO Acquires $616,700.00 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 35,000 shares of the stock in a transaction on Wednesday, April 29th. The stock was purchased at an average cost of...
MarketBeat
News Placeholder
Leon Moulder Jr Purchases 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were acquired at an...
MarketBeat
News Placeholder
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Rating of "Hold" by Analysts
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) has been given an average rating of "Hold" by the nine brokerages that are presently covering the firm, Marketbeat reports. Two investment...
MarketBeat
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results
Zenas BioPharma (NASDAQ:ZBIO - Get Free Report) posted its earnings results on Monday. The company reported ($1.10) earnings per share (EPS) for the quarter...
MarketBeat
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell?
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.